Answers are grounded in this paper and cite their sources.
Accurate etiologic diagnosis of heart failure, particularly HFpEF, is essential for developing and offering targeted therapies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2015) conducted an editorial in Heart failure, HFpEF, Wild-Type Transthyretin Amyloid Cardiomyopathy.
Synapse has enriched 10 related papers. Consider them for comparative context: